Christopher Aird Green

机构：University Hospitals Birmingham NHS Foundation Trust, Fermi National Accelerator Laboratory, Nuffield Orthopaedic Centre, Gloucestershire Hospitals NHS Foundation Trust, University Hospitals of Leicester NHS Trust, Abbott (United Kingdom), University of Oxford, Medawar Building for Pathogen Research, Cobalt Institute, Oxford BioMedica (United Kingdom), Oxford University Hospitals NHS Trust, NIHR Wellcome Trust Southampton Clinical Research Facility, NIHR Birmingham Biomedical Research Centre, University of Birmingham · ORCID：0000-0002-1984-4014

发表论文 276 篇 · 总被引 28353 次 · h-index 61

代表论文

• 2.0 - MOOSE: Enabling massively parallel multiphysics simulation (2022 · SoftwareX · 被引 241)
• GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 (2023 · Nature · 被引 234)
• Wastewater monitoring can anchor global disease surveillance systems (2023 · The Lancet Global Health · 被引 153)
• Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2023 · The Lancet · 被引 134)
• SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination (2022 · EBioMedicine · 被引 128)
• Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease (2024 · Nature Immunology · 被引 103)